LIFEVAX

Serial Number 90862832
606

Registration Progress

Application Filed
Aug 3, 2021
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Aug 23, 2025 23 days
Revival assistance for abandoned trademark

Trademark Image

LIFEVAX

Basic Information

Serial Number
90862832
Filing Date
August 3, 2021
Published for Opposition
March 22, 2022
Abandonment Date
June 23, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 23, 2025
Classes
005

Rights Holder

Luminis Holdings, Inc.

03
Address
7513 Connelley Drive, Suite I
Hanover, MD 21076

Ownership History

Luminis Holdings, Inc.

Original Applicant
03
Hanover, MD

Luminis Holdings, Inc.

Owner at Publication
03
Hanover, MD

Legal Representation

Attorney
Michael A. Geller

USPTO Deadlines

Next Deadline
23 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 23, 2025

Application History

32 events
Date Code Type Description Documents
Jun 23, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 23, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 3, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 3, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 8, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
May 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 7, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
May 7, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 2, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 2, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 13, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 11, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 11, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
May 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 4, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 2, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 2, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 16, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 14, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Prophylactic and therapeutic vaccines; immune cells for medical use; pharmaceutical preparations for stimulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and conditions

Classification

International Classes
005